Analysis of dual-chamber pacing as a treatment for refractory limiting symptoms in patients with obstructive hypertrophic cardiomyopathy

被引：0
|
作者：
Maron B.J. [1 ]
机构：
[1] Cardiovascular Research Division, Minneapolis Heart Institute Foundation, Minneapolis, MN 55407
来源：
Current Cardiology Reports | 2000年 / 2卷 / 2期
关键词：
Hypertrophic Cardiomyopathy; Obstructive Hypertrophic Cardiomyopathy; Pace Study; Left Ventricular Outflow Tract Gradient; Septal Myectomy;
D O I：
10.1007/s11886-000-0009-2
中图分类号：
学科分类号：
摘要：
Hypertrophic cardiomyopathy (HCM) is a genetically transmitted cardiac disease with a heterogeneous clinical expression and natural history [1]. A small but important proportion of patients with HCM develop exertional symptoms of dyspnea and chest pain refractory to drug treatment and have obstruction to left ventricular outflow under basal conditions (gradient, 50 mm Hg). Such patients probably constitute about 5% of the overall patient population with HCM at any one cross-sectional point in time. Copyright © 2000 by Current Science Inc.
引用
收藏
页码：131 / 133
页数：2
相关论文
共 50 条
  • [41] Comparison of Long-Term Effect of Dual-Chamber Pacing and Alcohol Septal Ablation in Patients with Hypertrophic Obstructive Cardiomyopathy
    Krejci, Jan
    Gregor, Pavel
    Zemanek, David
    Vyskocilova, Klaudia
    Curila, Karol
    Stepanova, Radka
    Novak, Miroslav
    Groch, Ladislav
    Veselka, Josef
    [J]. SCIENTIFIC WORLD JOURNAL, 2013,
  • [42] DUAL-CHAMBER PACING IN DILATED CARDIOMYOPATHY
    HOCHLEITNER, M
    FRIDRICH, L
    GSCHNITZER, F
    [J]. LANCET, 1993, 341 (8845): : 629 - 629
  • [43] ABORTED SUDDEN-DEATH IN DUAL-CHAMBER PACEMAKER TREATMENT OF HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY
    RUSCONI, P
    CHANDAR, J
    GARCIA, O
    YOUNG, ML
    [J]. AMERICAN HEART JOURNAL, 1995, 130 (04) : 912 - 915
  • [44] DUAL CHAMBER PACING - AN EFFECTIVE TREATMENT FOR HYPERTROPHIC CARDIOMYOPATHY
    ERWIN, J
    MCWILLIAMS, E
    GEARTY, G
    MAURER, B
    [J]. PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1985, 8 (03): : A34 - A34
  • [45] Assessment of dual-chamber pacing as a treatment for drug-refractory symptomatic patients with obstructive hypertrophic cardiomyopathy: A randomized, double-blind, crossover study (M-PATHY)
    Maron, BJ
    Nishimura, RA
    McKenna, WJ
    Rakowski, H
    Josephson, ME
    Kieval, RS
    [J]. CIRCULATION, 1998, 98 (17) : 506 - 506
  • [46] Comparison of dual-chamber pacing versus septal myectomy for the treatment of patients with hypertrophic obstructive cardiomyopathy - A comparison of objective hemodynamic and exercise end points
    Ommen, SR
    Nishimura, RA
    Squires, RW
    Schaff, HV
    Danielson, GK
    Tajik, AJ
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1999, 34 (01) : 191 - 196
  • [47] Impact of right atrial-left ventricular dual-chamber permanent pacing in patients with severely symptomatic hypertrophic obstructive cardiomyopathy
    Honda, T
    Shono, H
    Koyama, J
    Tsuchiya, T
    Hayashi, M
    Hirayama, T
    Uesugi, H
    Honda, T
    [J]. CIRCULATION JOURNAL, 2005, 69 (05) : 536 - 542
  • [48] LONG-TERM EFFECT OF DUAL-CHAMBER PACING ON LEFT-VENTRICULAR FUNCTION IN HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY
    JEANRENAUD, X
    GOY, JJ
    KAPPENBERGER, L
    [J]. CIRCULATION, 1992, 86 (04) : 447 - 447
  • [49] Hemodynamic rounds series II: Hemodynamics of dual-chamber pacing and valsalva maneuver in a patient with hypertrophic obstructive cardiomyopathy
    Kern, MJ
    Puri, S
    Donohue, TJ
    Bach, RG
    [J]. CATHETERIZATION AND CARDIOVASCULAR DIAGNOSIS, 1998, 44 (04): : 438 - 442
  • [50] Reverse left ventricular synchrony is a potential mechanism of the benefit from dual-chamber pacing in hypertrophic obstructive cardiomyopathy
    Ito, T
    Suwa, M
    Sakai, Y
    Tokaji, Y
    Hozumi, T
    Umeda, T
    Yamamoto, S
    Kitaura, Y
    [J]. CIRCULATION, 2004, 110 (17) : 633 - 633
12345